Three of us in the family had IV therapy after the holidays, this was a great pick me up
Unfortunately, the positive effects of GHK-Cu decline with age, as its concentration in the body decreases over time
supports hair follicle activity Common Research Uses Commonly studied for collagen and elastin synthesis and dermal extracellular matrix remodeling Researched in relation to wound healing, skin barrier repair, and angiogenesis Investigated for anti-aging skin applications and reduction of fine lines and laxity Studied in models of hair follicle activation and scalp health Researched for broad gene-regulatory activity and antioxidant pathway modulation Frequently studied in combination with BPC-157 and TB-500 for skin regeneration protocols Product Specifications Format: Lyophilized powder Vial size: 50mg or 100mg Storage: Freeze at 20C (lyophilized)
Dont assume any new symptom is benign while taking a compound without human safety data
Most recently, in March 2025, Fabhalta was approved as the first and only targeted treatment for complement 3 glomerulopathy (C3G), offering a disease-specific oral option for this ultra-rare kidney condition that previously lacked approved therapies